Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
Clinical trial NCT03014297 · TERMINATED
Trial details
- NCT number
- NCT03014297
- Sponsor
- Lowell Anthony, MD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2018-06-05
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.